Seeing Is Believing
Currently out of the existing stock ratings of Tony Ren, 1 are a SELL (50%), 1 are a BUY (50%).
Analyst Tony Ren, currently employed at JPMORGAN, carries an average stock price target met ratio of 100% that have a potential upside of 0.5% achieved within 10 days. Previously, Tony Ren worked at CLSA.
Tony Ren’s has documented 3 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BGNE, BeiGene Ltd at 13-Jan-2022.
Analyst best performing recommendations are on BGNE (BEIGENE LTD).
The best stock recommendation documented was for BGNE (BEIGENE LTD) at 3/1/2021. The price target of $321 was fulfilled within 10 days with a profit of $1.61 (0.5%) receiving and performance score of 0.5.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$319
7 months 11 days ago
(02-Dec-2024)
4/10 (40%)
$105.41 (49.35%)
105
Buy
$260
$75.29 (40.76%)
$254
8 months 1 days ago
(12-Nov-2024)
5/9 (55.56%)
$64.55 (33.03%)
150
Buy
$288
$103.29 (55.92%)
$285
11 months 6 days ago
(07-Aug-2024)
0/4 (0%)
$104.97 (57.35%)
Hold
$152.5
$-32.21 (-17.44%)
$164.3
1 years 5 days ago
(08-Jul-2024)
4/4 (100%)
$7.97 (5.51%)
103
Buy
$345
$160.29 (86.78%)
$350
1 years 4 months 17 days ago
(26-Feb-2024)
2/5 (40%)
$165.31 (92.00%)
350
What Year was the first public recommendation made by Tony Ren?